无胰胆疾病儿童常规2D MRI序列上胰管和胆总管的可见性及大小
该回顾性研究纳入177例因疑似阑尾炎或卵巢扭转在急诊行快速腹部MRI(非增强轴位和冠状位2D SSFSE序列)的儿童,排除胰胆异常者,由4名儿科放射科医师独立评估胰管各段及胆总管可见性和直径。结果显示胰管最大直径观察者均值为1.8 mm,胆总管均值为3.1 mm,并报告了按年龄的预期上限,可能有助于识别胰胆管异常。
要点
- 无胰胆疾病儿童胰管最大直径观察者均值1.8 mm,胆总管均值3.1 mm。
- 胰管各段可见性差异大,头段35.6-94.9%,尾段仅7.3-26.0%。
- 胆总管在所有患儿中均可见,预期直径5th-95th百分位为2.3-4.9 mm。
核心结论
- 报告了无胰胆疾病证据儿童在2D MR图像上胰管和胆总管测量的预期上限,可能有助于放射科医师在常规腹部MRI中识别胰胆管异常。
研究设计与样本
- 回顾性研究,纳入2023年1月23日至2023年9月13日在急诊因疑似阑尾炎或卵巢扭转行腹部MRI(非增强轴位和冠状位2D SSFSE序列)的患儿,排除MRI或实验室评估有胰腺或肝胆异常者,最终纳入177例(女112例,男65例;平均年龄12.3±3.4岁,范围5.1-17.7岁),由4名儿科放射科医师独立阅片。
关键影像表现/征象
- 胰管头段可见性35.6-94.9%,颈段18.6-72.3%,体段22.6-89.8%,尾段7.3-26.0%,四个节段均可见者为6.2-22.6%。
- 胆总管在所有患儿中均可见。
诊断标准与关键数值
- 胰管任何节段最大直径的观察者均值1.8 mm(观察者范围0.7-3.5 mm),观察者均值测量的5th-95th百分位预期最大直径为1.4-2.3 mm,预测区间上限从5岁的2.1 mm增至17岁的2.5 mm。
- 胆总管直径的观察者均值3.1 mm(观察者范围2.9-3.4 mm),观察者均值测量的5th-95th百分位预期直径为2.3-4.9 mm,预测区间上限从5岁的3.9 mm增至17岁的5.0 mm。
临床应用与阅片要点
- 作者指出这些发现可能有助于放射科医师在常规腹部MRI检查中识别胰胆管异常。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Pancreatic duct (PD) or common bile duct (CBD) dilatation can indicate ductal pathology, but limited data describe normal pediatric duct measurements on routine 2D MRI sequences. OBJECTIVE. The purpose of this study was to characterize the visibility and diameter of the PD and CBD on 2D MR images in children without pancreaticobiliary disease. METHODS. This retrospective study included patients who underwent abdominal MRI using a rapid protocol (composed of noncontrast axial and coronal 2D SSFSE sequences) to assess for suspected appendicitis or ovarian torsion in the emergency department setting between January 23, 2023, and September 13, 2023, and excluded patients with a pancreatic or hepatobiliary abnormality on MRI or laboratory assessment. Four pediatric radiologists independently reviewed examinations. Reviewers recorded PD visibility in each of four segments (i.e., head, neck, body, and tail) and CBD visibility, and reviewers measured PD diameter in each segment and maximal CBD diameter. Duct measurements by age were characterized by linear regression analyses. RESULTS. The study included 177 patients (112 female patients, 65 male patients; mean age, 12.3 ± 3.4 [SD] years [age range, 5.1-17.7 years]). The observers reported PD visibility in the head in 35.6-94.9% of patients, neck in 18.6-72.3%, body in 22.6-89.8%, and tail in 7.3-26.0% and reported PD visibility in all four segments in 6.2-22.6% of patients. Maximum PD diameter in any segment, as a mean across observers, was 1.8 mm (range across observers, 0.7-3.5 mm). The expected maximal PD diameter in any segment, in terms of the 5th and 95th percentile values of observers' mean measurements, was 1.4-2.3 mm; the prediction interval's upper limit increased from age 5 to age 17 from 2.1 to 2.5 mm. All observers reported CBD visibility in all patients. The mean CBD diameter across observers was 3.1 mm (range across observers, 2.9-3.4 mm). The expected CBD diameter, in terms of the 5th and 95th percentile values of observers' mean measurements, was 2.3-4.9 mm; the prediction interval's upper limit increased from age 5 to age 17 from 3.9 to 5.0 mm. CONCLUSION. We report expected upper limits for PD and CBD measurements on 2D MR images in children without evidence of pancreaticobiliary disease. CLINICAL IMPACT. These findings may aid radiologists' identification of pancreaticobiliary duct abnormalities on routine abdominal MRI examinations.
引用
- Kocaoglu M, Ata NKA, Smith EA, et al. Visibility and Size of the Pancreatic Duct and Common Bile Duct on Routine 2D MRI Sequences in Children Without Pancreaticobiliary Disease. AJR Am J Roentgenol. 2024. PMID: 38775436. doi:10.2214/AJR.24.31347
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。